A Single-Center Experience With Total Percutaneous Implantation of a Low-Profile Thoracic Aortic Stent-Graft

Abstract

Purpose:

To evaluate the safety and effectiveness of total percutaneous implantation of the Zenith Alpha Thoracic (ZTA) endograft in the treatment of diseases of the descending thoracic aorta.

Materials and Methods:

A retrospective cohort study of 56 consecutive patients undergoing total percutaneous ZTA implantation between 2018 and 2020 was performed in a single center. Patients’ demographics, clinical characteristics, anatomical parameters, operative details, device features, and postoperative outcomes were assessed. The primary endpoint was ongoing clinical success. A Cox regression model was used to determine the predictive factors of worse postoperative outcomes.

Results:

Eighty-three ZTA endografts were implanted in 35 men and 21 women with a mean age of 69±11 years for the treatment of 26 degenerative aneurysms, 15 type B dissections, and 8 penetrating ulcers, among others. Primary technical success was 100%, with a 30-day ongoing clinical success rate of 94.6%. The 1-year ongoing clinical success rate was 91.1% (51 patients), and freedoms from all-cause mortality, type 1 and 3 endoleaks, and any unplanned reintervention were, respectively, 95.3%, 91.4%, and 88.2% at 1 year. During follow-up, there was one case of surgical conversion for an aorto-esophageal fistula. On the contrary, neither aneurysmal rupture nor significant aneurysmal expansion was recorded. Repair of ruptured thoracic aorta and a high ratio of sheath outer diameter to external iliac artery diameter were found to be independently associated with worse outcomes, with adjusted odds ratios of 4.4 [1.5-15.3] and 4.9 [1.1-23.9], respectively.

Conclusion:

The outcomes of total percutaneous implantation of ZTA endograft show excellent primary technical success and favorable midterm ongoing clinical success. Factors associated with worse outcomes include the repair of ruptured aorta and a high sheath to access vessel ratio.

Keywords

TEVAR thoracic aneurysm type B dissection penetrating aortic ulcer endovascular repair thoracic endograft low profile aortic stent-graft

Get full access to this article

View all access options for this article.

References

Upchurch

Jr Escobar

Azizzadeh

, et al. Society for Vascular Surgery clinical practice guidelines of thoracic endovascular aortic repair for descending thoracic aortic aneurysms. J Vasc Surg. 2021;73(suppl 1):55S–83S. doi:10.1016/j.jvs.2020.05.076.

Riambau

Böckler

Brunkwall

, et al. Editor’s choice: management of descending thoracic aorta diseases: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2017;53(1):4–52. doi:10.1016/j.ejvs.2016.06.005.

Harky

Kai Chan

Ming Wong

, et al. Open versus endovascular repair of descending thoracic aortic aneurysm disease: a systematic review and meta-analysis. Ann Vasc Surg. 2019;54:304–315.e5. doi:10.1016/j.avsg.2018.05.043.

Harky

Bleetman

Chan

JSK

, et al. A systematic review and meta-analysis of endovascular versus open surgical repair for the traumatic ruptured thoracic aorta. J Vasc Surg. 2020;71(1):270–282. doi:10.1016/j.jvs.2019.05.011.

Abraha

Romagnoli

Montedori

, et al. Thoracic stent graft versus surgery for thoracic aneurysm. Cochrane Database Syst Rev. 2016;2016(6):CD006796. doi:10.1002/14651858.CD006796.pub4.

Melissano

Tshomba

Rinaldi

, et al. Initial clinical experience with a new low-profile thoracic endograft. J Vasc Surg. 2015;62(2):336–342. doi:10.1016/j.jvs.2015.02.049.

Jackson

Woo

Bavaria

, et al. Gender analysis of the pivotal results of the Medtronic Talent Thoracic Stent Graft System (VALOR) trial. J Vasc Surg. 2011;54(2):358–363.e1. doi:10.1016/j.jvs.2010.12.064.

Masuda

Caps

Singh

, et al. Effect of ethnicity on access and device complications during endovascular aneurysm repair. J Vasc Surg. 2004;40(1):24–29. doi:10.1016/j.jvs.2004.02.035.

Torsello

Austermann

Van Aken

, et al. Initial clinical experience with the Zenith Alpha stent-graft. J Endovasc Ther. 2015;22(2):153–159. doi:10.1177/1526602815573239.

10.

Tsilimparis

Abicht

J-M

Stana

, et al. The Munich Valsalva Implantation Technique (MuVIT) for cardiac output reduction during TEVAR: vena cava occlusion with the Valsalva maneuver. J Endovasc Ther. 2021;28(1):7–13. doi:10.1177/1526602820961376.

11.

Fillinger

Greenberg

McKinsey

, et al. Reporting standards for thoracic endovascular aortic repair (TEVAR). J Vasc Surg. 2010;52(4):1022–1033.e5. doi:10.1016/j.jvs.2010.07.008.

12.

Illig

Ohki

Hughes

, et al. One-year outcomes from the international multicenter study of the Zenith Alpha Thoracic Endovascular Graft for thoracic endovascular repair. J Vasc Surg. 2015;62(6):1485–1494.e2. doi:10.1016/j.jvs.2015.05.007.

13.

Beropoulis

Fazzini

Austermann

Torsello

Damerau

Torsello

. Long-term results of thoracic endovascular aortic repair using a low-profile stent-graft. J Endovasc Ther. 2021;28(1):56–62. doi:10.1177/1526602820952416.

14.

Torsello

Inchingolo

Austermann

, et al. Durability of a low-profile stent graft for thoracic endovascular aneurysm repair. J Vasc Surg. 2017;66(6):1638–1643. doi:10.1016/j.jvs.2017.04.042.

15.

Melissano

Rinaldi

Mascia

, et al. Single-center midterm results with the low-profile Zenith Alpha thoracic endovascular stent graft. J Vasc Surg. 2021;73:1533–1540.e2. doi:10.1016/j.jvs.2020.10.003.

16.

Tolenaar

de Vries

JP.

Commentary: new low-profile zenith alpha stent-graft for the treatment of thoracic aortic disease: a real breakthrough?

J Endovasc Ther. 2015;22(2):160–162. doi:10.1177/1526602815573247.

17.

Choi

Kim

S-P

Lee

, et al. Clinical outcomes of endovascular treatment for ruptured thoracic aortic disease. Korean J Intern Med. 2021;36(suppl 1):S72–S79. doi:10.3904/kjim.2019.080.

18.

Ultee

KHJ

Zettervall

Soden

, et al. The impact of endovascular repair on management and outcome of ruptured thoracic aortic aneurysms. J Vasc Surg. 2017;66(2):343–352.e1. doi:10.1016/j.jvs.2017.01.026.

19.

Kilic

Shah

Black

3rd , et al. Trends in repair of intact and ruptured descending thoracic aortic aneurysms in the United States: a population-based analysis. J Thorac Cardiovasc Surg. 2014;147(6):1855–1860. doi:10.1016/j.jtcvs.2013.06.032.

20.

Peterson

Matsumura

JS.

Tips and tricks for avoiding access problems when using large sheath endografts. J Vasc Surg. 2009;49(2):524–527. doi:10.1016/j.jvs.2008.11.047.

21.

Parker

Mukherjee

Ryan

Management of large bore access complications in the era of trans-catheter aortic valve replacement. Vascular. 2021;29:610–615. doi:10.1177/1708538120969468.

22.

Kaki

Alraies

Kajy

, et al. Large bore occlusive sheath management. Catheter Cardiovasc Interv. 2019;93(4):678–684. doi:10.1002/ccd.28101.

23.

Lejay

Caspar

Ohana

, et al. Vascular access complications in endovascular procedures with large sheaths. J Cardiovasc Surg (Torino). 2016;57(2):311–321.

24.

de Souza

Oderich

Banga

, et al. Outcomes of total percutaneous endovascular aortic repair for thoracic, fenestrated, and branched endografts. J Vasc Surg. 2015;62(6):1442–1449.e3. doi:10.1016/j.jvs.2015.07.072.

25.

Dimitriadis

Scholtz

Ensminger

, et al. Impact of sheath diameter of different sheath types on vascular complications and mortality in transfemoral TAVI approaches using the Proglide closure device. PLoS ONE. 2017;12:e0183658. doi:10.1371/journal.pone.0183658.

26.

Hayashida

Lefévre

Chevalier

, et al. Abstract 19273: impact of sheath-femoral artery diameter ratio on predicting vascular complications in femoral transcatheter aortic valve implantation. Circulation. 2010;122(suppl 21):A19273. doi:10.1161/circ.122.suppl_21.A19273.

27.

Spencer

Mahoney

KJ.

Reducing catheter-related thrombosis using a risk reduction tool centered on catheter to vessel ratio. J Thromb Thrombolysis. 2017;44(4):427–434. doi:10.1007/s11239-017-1569-y.